Implementation of a nurse-enabled, shared-care follow-up model for early breast cancer survivors (The IBIS-Survivorship Study)

Not Applicable

Recruiting

• Conditions: Breast Cancer; Cancer - Breast

• Registration Number: ACTRN12621000188831
• Lead Sponsor: Professor Raymond Chan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-02-22
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1358

Inclusion Criteria

Early breast cancer as defined as stage I-III (inclusive of ductal carcinoma in situ (DCIS) and locally advanced breast cancer but no distant metastases) who are:
- within ten weeks of completion of adjuvant treatment for early stage breast cancer at a participating site; OR within ten weeks post-surgery if not scheduled for further adjuvant therapy;
- Can identify a regular GP;
- Ambulatory with Eastern Cooperative Oncology Group (ECOG) performance status of 0-2; and
- Able to read and understand English.

Recurrent or secondary primary breast cancer, comorbidities, other prior cancer diagnoses or Trastuzumab (or biosimilars), neoadjuvant and/or ongoing endocrine therapies are NOT exclusion criteria

Exclusion Criteria

- have metastatic (distant) breast cancer; or
- the presence of severe mental, cognitive or physical conditions that would limit the patient’s ability to participate at the discretion of treating clinicians

Study & Design

• Study Type: Interventional
• Study Design: Not specified